Reduced /V-acetylaspartate concentration in temporal lobe epilepsy by quantitative 1H MRS in vivo
- 1 September 1994
- journal article
- clinical trial
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 5 (14) , 1733-1736
- https://doi.org/10.1097/00001756-199409080-00011
Abstract
We used proton magnetic resonance spectroscopy (1H MRS) to determine concentrations of N-acetylaspartate (NAA), creatine and choline in vivo (63 MHz) and in vitro (400 MHz) in seven patients undergoing surgical treatment of intractable temporal lobe epilepsy (TLE). Nine healthy volunteers were used as controls for in vivo MRS. NAA concentrations in vivo on the ipsilateral and contralateral sides were 6.5 +/- 1.3 (s.d.) and 7.9 (+/- 2.1) mmol l-1, respectively and 8.6 (+/- 0.8) mmol l-1 in the volunteers. NAA concentration in vitro was 3.2 (+/- 0.9) mumol g-1 wet weight (ww) and the corresponding concentration from the macroscopically intact brain tissue was 4.7 (+/- 1.0) mumol g-1 ww. Thus, in vivo quantitative 1H MRS identified the size of seizure focus in patients with temporal lobe epilepsy.Keywords
This publication has 0 references indexed in Scilit: